111 related articles for article (PubMed ID: 26163455)
1. The contribution of the major metabolite 4'-O-methylmonoHER to the antioxidant activity of the flavonoid monoHER.
Lemmens KJ; Herst PM; Housmans BA; Moalin M; van der Vijgh WJ; Bast A; Haenen GR
Chem Biol Interact; 2015 Sep; 239():146-52. PubMed ID: 26163455
[TBL] [Abstract][Full Text] [Related]
2. The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect.
Lemmens KJ; van de Wier B; Vaes N; Ghosh M; van Zandvoort MA; van der Vijgh WJ; Bast A; Haenen GR
Toxicol In Vitro; 2014 Jun; 28(4):538-43. PubMed ID: 24412621
[TBL] [Abstract][Full Text] [Related]
3. Identification of the metabolites of the antioxidant flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside in mice.
Jacobs H; Peters R; den Hartog GJ; van der Vijgh WJ; Bast A; Haenen GR
Drug Metab Dispos; 2011 May; 39(5):750-6. PubMed ID: 21266594
[TBL] [Abstract][Full Text] [Related]
4. An essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant network.
Jacobs H; Moalin M; Bast A; van der Vijgh WJ; Haenen GR
PLoS One; 2010 Nov; 5(11):e13880. PubMed ID: 21079733
[TBL] [Abstract][Full Text] [Related]
5. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
[TBL] [Abstract][Full Text] [Related]
6. Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profile.
Jacobs H; Koek GH; Peters R; Moalin M; Tack J; van der Vijgh WJ; Bast A; Haenen GR
Clin Pharmacol Ther; 2011 Dec; 90(6):852-9. PubMed ID: 22048223
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the glutathione conjugate of the semisynthetic flavonoid monoHER.
Jacobs H; van der Vijgh WJ; Koek GH; Draaisma GJ; Moalin M; van Strijdonck GP; Bast A; Haenen GR
Free Radic Biol Med; 2009 Jun; 46(12):1567-73. PubMed ID: 19272444
[TBL] [Abstract][Full Text] [Related]
8. The flavonoid monoHER promotes the adaption to oxidative stress during the onset of NAFLD.
Lemmens KJ; van de Wier B; Koek GH; Köhler E; Drittij MJ; van der Vijgh WJ; Bast A; Haenen GR
Biochem Biophys Res Commun; 2015 Jan; 456(1):179-82. PubMed ID: 25462563
[TBL] [Abstract][Full Text] [Related]
9. The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB.
Jacobs H; Bast A; Peters GJ; van der Vijgh WJ; Haenen GR
Br J Cancer; 2011 Feb; 104(3):437-40. PubMed ID: 21245867
[TBL] [Abstract][Full Text] [Related]
10. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
11. An essential difference in the reactivity of the glutathione adducts of the structurally closely related flavonoids monoHER and quercetin.
Jacobs H; Moalin M; van Gisbergen MW; Bast A; van der Vijgh WJ; Haenen GR
Free Radic Biol Med; 2011 Dec; 51(11):2118-23. PubMed ID: 21982895
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
[TBL] [Abstract][Full Text] [Related]
13. The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro.
Abou El Hassan MA; Verheul HM; Jorna AS; Schalkwijk C; van Bezu J; van der Vijgh WJ; Bast A
Br J Cancer; 2003 Jul; 89(2):357-62. PubMed ID: 12865930
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice.
Bruynzeel AM; Vormer-Bonne S; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2007 Sep; 60(4):509-14. PubMed ID: 17177067
[TBL] [Abstract][Full Text] [Related]
15. 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.
van Acker FA; van Acker SA; Kramer K; Haenen GR; Bast A; van der Vijgh WJ
Clin Cancer Res; 2000 Apr; 6(4):1337-41. PubMed ID: 10778960
[TBL] [Abstract][Full Text] [Related]
16. Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity.
van Acker SA; Kramer K; Grimbergen JA; van den Berg DJ; van der Vijgh WJ; Bast A
Br J Pharmacol; 1995 Aug; 115(7):1260-4. PubMed ID: 7582554
[TBL] [Abstract][Full Text] [Related]
17. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
18. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids as protectors against doxorubicin cardiotoxicity: role of iron chelation, antioxidant activity and inhibition of carbonyl reductase.
Kaiserová H; Simůnek T; van der Vijgh WJ; Bast A; Kvasnicková E
Biochim Biophys Acta; 2007 Sep; 1772(9):1065-74. PubMed ID: 17572073
[TBL] [Abstract][Full Text] [Related]
20. A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.
Abou-El-Hassan MA; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Br J Cancer; 2003 Dec; 89(11):2140-6. PubMed ID: 14647150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
